Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

1
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis

Results Analysis

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Category

Show more Refine

For: Kim JK, Park SU. Recent insights into the biological and pharmacological activity of lycopene. EXCLI J 2022;21:415-425. [PMID: 35391916 PMCID: PMC8983849 DOI: 10.17179/excli2022-4714] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/25/2022] [Accepted: 02/10/2022] [Indexed: 12/27/2022]

For:	Kim JK, Park SU. Recent insights into the biological and pharmacological activity of lycopene. EXCLI J 2022;21:415-425. [PMID: 35391916 PMCID: PMC8983849 DOI: 10.17179/excli2022-4714] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/25/2022] [Accepted: 02/10/2022] [Indexed: 12/27/2022]

Number	Cited by Other Article(s)
1	Magne TM, da Silva de Barros AO, de Almeida Fechine PB, Alencar LMR, Ricci-Junior E, Santos-Oliveira R. Lycopene as a Multifunctional Platform for the Treatment of Cancer and Inflammation. REVISTA BRASILEIRA DE FARMACOGNOSIA 2022. [DOI: 10.1007/s43450-022-00250-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Magne TM, da Silva de Barros AO, de Almeida Fechine PB, Alencar LMR, Ricci-Junior E, Santos-Oliveira R. Lycopene as a Multifunctional Platform for the Treatment of Cancer and Inflammation. REVISTA BRASILEIRA DE FARMACOGNOSIA 2022. [DOI: 10.1007/s43450-022-00250-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]